Bupropion treatment for cocaine abuse and adult attention-deficit/hyperactivity disorder.
about
Antidepressants for cocaine dependence and problematic cocaine useAgonist replacement for stimulant dependence: a review of clinical researchEthanol-BDNF interactions: still more questions than answers.A practical guide to recognition and diagnosis of ADHD in adults in the primary care setting.Treatment modalities for patients with gambling disorder.Structural alterations in the prefrontal cortex mediate the relationship between Internet gaming disorder and depressed moodPavlovian drug discrimination with bupropion as a feature positive occasion setter: substitution by methamphetamine and nicotine, but not cocaine.An update on the pharmacotherapy of attention-deficit/hyperactivity disorder in adultsLisdexamfetamine dimesylate for the treatment of attention deficit hyperactivity disorder in adults with a history of depression or history of substance use disorder.The utility of rat models of impulsivity in developing pharmacotherapies for impulse control disorders.An Open Trial of Sustained Release Bupropion for Attention-Deficit/Hyperactivity Disorder in Adults with ADHD plus Substance Use Disorders.Adult ADHD and substance abuse: diagnostic and treatment issues.Treatments for Adolescents With Comorbid ADHD and Substance Use Disorder: A Systematic Review.Substance-use disorders in adolescents and adults with ADHD: focus on treatment.Therapeutic challenges of attention-deficit hyperactivity disorder with substance use disorders.Cocaine and opioid use during pregnancy: prevalence and management.Effects of major depressive disorder and attention-deficit/hyperactivity disorder on the outcome of treatment for cocaine dependence.Treatment strategies for co-occurring ADHD and substance use disordersAtomoxetine Treatment for Cocaine Abuse and Adult Attention-Deficit Hyperactivity Disorder (ADHD): A Preliminary Open Trial.A preliminary trial: double-blind comparison of nefazodone, bupropion-SR, and placebo in the treatment of cannabis dependence.Comorbidity and its impact in adult patients with attention-deficit/hyperactivity disorder: a primary care perspective.Pharmacological and clinical dilemmas of prescribing in co-morbid adult attention-deficit/hyperactivity disorder and addiction.Attention deficit hyperactivity disorder and substance misuse: an evaluation of causal hypotheses and treatment considerations.Alternative pharmacological strategies for adult ADHD treatment: a systematic review.Guidelines of the Brazilian Association of Studies on Alcohol and Other Drugs (ABEAD) for diagnosis and treatment of psychiatric comorbidity with alcohol and other substance and dependence.Expert Opinion and Recommendations for the Management of Attention-Deficit/Hyperactivity Disorder in Correctional Facilities.Adult ADHD and comorbid disorders: clinical implications of a dimensional approach.Stimulant medication for ADHD in opioid maintenance treatment.A case of treating cathinone dependence and comorbid depression using bupropion.Neuropharmacology of Attention-Deficit/Hyperactivity DisorderSustain Released Bupropion in the Treatment of Tricotillomania: Outpatient Follow Up Survey
P2860
Q24234248-404D895F-016A-4598-875E-1D43013BA1D5Q27014854-992CBCB5-5773-4D86-927F-3A4B4568B836Q30490427-4533FFDB-D76C-4476-A7CE-EE7C8C7578DEQ33372713-EB794117-AD2D-4BFF-ACD8-4BFE5B7DB7CFQ33617805-71A81CBA-C299-457A-A2F9-C0465BB7622BQ33682148-F1E00016-4D21-4880-A0DC-B7446FF2AF24Q34060576-7700E465-26D2-41BD-B770-032281A3BCFAQ34220004-94116F38-EFDC-49AF-83E5-0AD926F8127BQ34763735-FFCDAC47-C029-4616-81AD-B901ED305828Q35589965-78BBD97E-9DB1-4CE8-A29B-E9A46784F3F5Q35878684-9ACD92CD-1E6F-4CBB-80F3-AA617734DE07Q36311022-32666DDA-B268-4D9C-A510-7351F0CB5E03Q36338808-8913B593-289A-47CE-A3FE-9A43D4CEA582Q36344412-EC13FB10-A79C-44CC-944F-3DBB565ACA8AQ36453288-286CDFFE-F59C-40F1-980E-034F8B39EFBDQ36474136-5571BD19-8A79-41AF-BB8E-023A20BA0405Q36478373-E8F001EF-E777-44E1-BEED-286082B2C52AQ36799361-7928B66A-E1D7-4E51-BF7D-BDBD953167A7Q37185366-046F5028-9ECA-48DF-9543-D87CA71AF093Q37381180-E94DD732-B76C-45AA-BA5A-360E993B218DQ37505871-9505CDF2-CDCB-4631-8753-F31A1793E7DEQ38065287-ADA19671-58D4-4E17-81C2-506FD47A7289Q38569727-FEC59933-7997-46D2-A082-99D90BF64B62Q38676199-8F1D42A6-912C-4CA8-ADB0-98376B96EE54Q38740139-D04CBD98-A75F-41A3-A077-D15CE997480AQ40207289-0E93D55F-96ED-4B5B-9762-F259C6CE05D4Q41495299-3E1C487A-6017-48E9-B3CC-54858AB4AF7CQ44348151-FFD9BFAB-3836-468A-88F5-24900D5EB3DCQ48505716-4833D0AC-EDF3-442A-8DD9-8FE1C7C37255Q57277979-494979B1-AFD3-4CD0-8E75-04F7E0984CC6Q58650595-9ACBC4A2-34E4-406B-A32B-6E3F18954CEE
P2860
Bupropion treatment for cocaine abuse and adult attention-deficit/hyperactivity disorder.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Bupropion treatment for cocaine abuse and adult attention-deficit/hyperactivity disorder.
@en
type
label
Bupropion treatment for cocaine abuse and adult attention-deficit/hyperactivity disorder.
@en
prefLabel
Bupropion treatment for cocaine abuse and adult attention-deficit/hyperactivity disorder.
@en
P2093
P2860
P356
P1476
Bupropion treatment for cocaine abuse and adult attention-deficit/hyperactivity disorder.
@en
P2093
Daniel J Brooks
David M McDowell
Edward Nunes
Frances R Levin
Suzette M Evans
P2860
P356
10.1300/J069V21N02_01
P577
2002-01-01T00:00:00Z